FGFR3 Gene Mutation
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer (NCT04917809) | Memorial Sloan Kettering Cancer Center | 2022-02-17 |
| Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372) | xCures | 2021-11-21 |
| Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations (NCT04096417) | Academic and Community Cancer Research United | 2020-08-31 |
| BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer (NCT02706691) | University of Chicago | 2018-06-01 |
| Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer (NCT02965378) | SWOG Cancer Research Network | 2014-10-01 |
Track FGFR3 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.